Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and Characterization of a Highly Virulent Getah Virus Causing Acute Lethal Infection in Neonatal Piglets.

Transboundary and emerging diseases·2026
Same author

Genetic Spectrum of Hemoglobinopathies in Reproductive-Age Individuals from a Hospital-Based Cohort in Guangdong, China: A 7-Year Retrospective Analysis.

Biomedicines·2026
Same author

Effects of High-Altitude Environments on Gut Microbiota and Their Mechanisms in Immune Regulation and High-Altitude Adaptation.

International journal of molecular sciences·2026
Same author

Advances in immune-inflammatory interactions within the testicular-penile microenvironment of varicocele patients: molecular mechanisms underlying erectile dysfunction and spermatogenic impairment.

Frontiers in endocrinology·2026
Same author

Multi-source Fusion Positioning Revisited by Drawing on Human Thinking Process.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

Association of peripheral blood NLRP3, sTREM2, and p-tau217 levels with cognitive outcomes in patients with chronic alcohol-related brain damage.

Alcohol and alcoholism (Oxford, Oxfordshire)·2026

Related Experiment Video

Updated: May 26, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.8K

Comparative study of third-generation sequencing-based CASMA-trio and STR linkage analysis for identifying SMN1 2 + 0

Jianchun He1,2,3,4, Wenzhi He1,2,3,4, Jiajia Xian1,2,3,4

  • 1Department of Obstetrics and Gynecology, Experimental Department of Obstetrics and Gynecology Institute, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, Guangdong, China.

Scientific Reports
|February 21, 2025
PubMed
Summary

Accurate identification of Spinal Muscular Atrophy (SMA) carriers with the SMN1 2+0 genotype is now possible using Comprehensive Analysis of SMA trios (CASMA-trio). This method offers a broader application prospect for SMA carrier screening.

Keywords:
SMN1 2 + 0 carrierSTR linkage analysisSpinal muscular atrophyThird-generation sequencing

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.4K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

12.9K

Related Experiment Videos

Last Updated: May 26, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.8K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.4K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

12.9K

Area of Science:

  • Genetics and Genomics
  • Neuromuscular Disorders
  • Molecular Diagnostics

Background:

  • Spinal Muscular Atrophy (SMA) is an autosomal recessive neuromuscular disorder.
  • Defects in the Survival Motor Neuron (SMN) gene cause SMA.
  • The SMN1 gene is the primary pathogenic gene, with high homology to SMN2.

Purpose of the Study:

  • To evaluate the Comprehensive Analysis of SMA (CASMA) method for detecting SMN1 and SMN2 copy numbers.
  • To identify unique SMA carriers with the SMN1 2+0 genotype using CASMA-trio analysis.
  • To compare CASMA-trio with Multiplex Ligation-dependent Probe Amplification (MLPA) and Short Tandem Repeat (STR) linkage analysis.

Main Methods:

  • Third-generation sequencing technology (CASMA) was employed to determine SMN1 and SMN2 copy numbers.
  • CASMA-trio utilized SMN1 haplotypes in parent-child trios for carrier identification.
  • Results were cross-validated against MLPA combined with STR linkage analysis.

Main Results:

  • CASMA and MLPA showed concordant SMN1/SMN2 copy numbers in 25 peripheral blood samples.
  • CASMA-trio identified 5 individuals as SMN1 2+0 carriers across 4 families, consistent with STR analysis.
  • CASMA-trio demonstrated a broader application prospect compared to STR linkage analysis for carrier screening.

Conclusions:

  • CASMA shows potential for accurate SMN1 and SMN2 copy number detection.
  • CASMA-trio simplifies the analysis of SMN1 2+0 carriers by requiring only parent-child trios.
  • Implementing CASMA-trio can enhance comprehensive screening for SMA carriers.